120 related articles for article (PubMed ID: 8793841)
1. Lack of correlation between different hepatitis C virus screening and confirmatory assays.
Berger A; Doerr HW; Preiser W; Weber B
J Virol Methods; 1996 May; 59(1-2):141-6. PubMed ID: 8793841
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
[TBL] [Abstract][Full Text] [Related]
3. Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection.
Bossi V; Galli C
J Clin Virol; 2004 May; 30(1):45-9. PubMed ID: 15072753
[TBL] [Abstract][Full Text] [Related]
4. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody.
Dussaix E; Charnaux N; Laurent-Puig P; Chopineau S; Laurian Y; Buffet C
J Clin Microbiol; 1994 Sep; 32(9):2071-5. PubMed ID: 7529247
[TBL] [Abstract][Full Text] [Related]
5. E2 and NS5: new antigens for detection of hepatitis C virus antibodies.
Zaaijer HL; Vallari DS; Cunningham M; Lesniewski R; Reesink HW; van der Poel CL; Lelie PN
J Med Virol; 1994 Dec; 44(4):395-7. PubMed ID: 7534821
[TBL] [Abstract][Full Text] [Related]
6. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
Engel PM; Dennin RH
Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
[TBL] [Abstract][Full Text] [Related]
7. Development of low cost peptide-based anti-hepatitis C virus screening and confirmatory assays: comparison with commercially available tests.
Palacios A; Taylor L; Haue L; Luftig RB; Visoná KA
J Med Virol; 1999 Jul; 58(3):221-6. PubMed ID: 10447416
[TBL] [Abstract][Full Text] [Related]
8. A comparative evaluation of the sensitivity of five anti-hepatitis C virus immunoblot assays.
Couroucé AM; Noel L; Barin F; Elghouzzi MH; Lunel F; North ML; Smilovici W
Vox Sang; 1998; 74(4):217-24. PubMed ID: 9691401
[TBL] [Abstract][Full Text] [Related]
9. Early detection of anti-HCc antibody in acute hepatitis C virus (HCV) by western blot (immunoblot) using a recombinant HCV core protein fragment.
Yeh CT; Han CM; Lo SY; Ou JH; Fan KD; Sheen IS; Chu CM; Liaw YF
J Clin Microbiol; 1994 Sep; 32(9):2235-41. PubMed ID: 7529251
[TBL] [Abstract][Full Text] [Related]
10. Study on reliability of commercially available hepatitis C virus antibody tests.
Feucht HH; Zöllner B; Polywka S; Laufs R
J Clin Microbiol; 1995 Mar; 33(3):620-4. PubMed ID: 7751366
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
12. Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors.
Attia MA; Zekri AR; Goudsmit J; Boom R; Khaled HM; Mansour MT; de Wolf F; el-Din HM; Sol CJ
J Clin Microbiol; 1996 Nov; 34(11):2665-9. PubMed ID: 8897161
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
Gonçales NS; Costa FF; Vassallo J; Gonçales FL
Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
[TBL] [Abstract][Full Text] [Related]
14. Human antibodies to dengue and yellow fever do not react in diagnostic assays for hepatitis C virus.
Yoshida CF; Rouzerè CD; Nogueira RM; Lampe E; Travassos-da-Rosa MA; Vanderborght BO; Schatzmayr HG
Braz J Med Biol Res; 1992; 25(11):1131-5. PubMed ID: 1285268
[TBL] [Abstract][Full Text] [Related]
15. Confirmation of hepatitis C infection: a comparison of five immunoblot assays.
Zaaijer HL; Vrielink H; van Exel-Oehlers PJ; Cuypers HT; Lelie PN
Transfusion; 1994 Jul; 34(7):603-7. PubMed ID: 7519796
[TBL] [Abstract][Full Text] [Related]
16. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
[TBL] [Abstract][Full Text] [Related]
17. Limits of diagnostic accuracy of anti-hepatitis C virus antibodies detection by ELISA and immunoblot assay.
Suslov AP; Kuzin SN; Golosova TV; Shalunova NV; Malyshev NA; Sadikova NV; Vavilova LM; Somova AV; Musina EE; Ivanova MV; Kipor TT; Timonin IM; Kuzina LE; Godkov MA; Bajenov AI; Nesterenko VG
Russ J Immunol; 2002 Jul; 7(2):175-84. PubMed ID: 12687261
[TBL] [Abstract][Full Text] [Related]
18. Significance of anti-E2 in the diagnosis of HCV infection in patients on maintenance hemodialysis: anti-E2 is frequently detected among anti-HCV antibody-negative patients.
Lee DS; Lesniewski RR; Sung YC; Min WK; Park SG; Lee KH; Kim HS
J Am Soc Nephrol; 1996 Nov; 7(11):2409-13. PubMed ID: 8959633
[TBL] [Abstract][Full Text] [Related]
19. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
Bååth L; Widell A; Nordenfelt E
J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
[TBL] [Abstract][Full Text] [Related]
20. GB virus C/hepatitis G virus infection in hemodialysis patients: determination of seroprevalence by a four-antigen recombinant immunoblot assay.
Schröter M; Feucht HH; Schäfer P; Zöllner B; Laufs R
J Med Virol; 1999 Mar; 57(3):230-4. PubMed ID: 10022792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
